Delivery Order SPE2DB20D1004-SPE2DB23FG4L7
Award Date
8/28/23
Potential Completion Date
8/29/23
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $21,907.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xeljanz XR 11 mg tablets, a prescription medication, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xeljanz 10 mg tablets, a specialty medication used to treat various medical conditions. The award has a ceiling value of $13,216.34 and an ultimate completion date of December 20, 2023. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Xeljanz XR 11 mg tablets. The contract has a ceiling value of $3,234.68 and is a firm fixed-price delivery order with a completion date of May 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
The federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $3,470.13 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a completion date of October 29, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of the pharmaceutical product Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,399.29, is for the supply of Xeljanz 5 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $4,685.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xeljanz XR 11 mg tablets, a specialty medication used for various medical conditions. It is a firm-fixed-price delivery order with a completion date of March 7, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF5K9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Xeljanz XR 11 mg tablets. The contract has a ceiling value of $7,719.51 and an ultimate completion date of April 21, 2022. This order was placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Xeljanz XR 11 mg tablets to the agency. The contract is a delivery order valued at $1,507.35, with a completion date of April 17, 2024. The contract is a firm fixed-price agreement and is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award, valued at $6,164.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Xeljanz XR 11 mg tablets, a pharmaceutical product used to treat various medical conditions. The contract is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through...